Abstract
Although primary hyperhidrosis has no apparent underlying cause, secondary hyperhidrosis can be caused by substance abuse as well as neurologic, endocrine, infectious, and malignant disorders. Focal hyperhidrosis is confined to one or more body regions (e.g., the palms, foot soles, or axillae), whereas generalized hyperhidrosis involves the entire body surface. Excessive sweating of the palms can be a cofactor for hand eczema. Thus, hyperhidrosis may facilitate the development of allergic contact dermatitis or act in concert with irritants in the development of irritant contact dermatitis. Hand eczema may also be an adverse effect of the treatment of palmar hyperhidrosis. Treatment modalities for hyperhidrosis include topical antiperspirants, iontophoresis, botulinum toxin A injections, systemic anticholinergics, and surgical denervation of the thoracic sympathetic chain. These are briefly discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Renbourn ET. The history of sweat and the sweat rash from earliest times to the end of the 18th century. J Hist Med Allied Sci. 1959;14(2):202–27.
Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: evidence of genetic transmission. J Vasc Surg. 2002;35(2):382–6.
Jensen O. ‘Rusters’. The corrosive action of palmar sweat: I. Sodium chloride in sweat. Acta Derm Venereol. 1979;59(2):135–8.
Jensen O, Nielsen E. “Rusters”. The corrosive action of palmar sweat: II. Physical and chemical factors in palmar hyperhidrosis. Acta Derm Venereol. 1979;59(2):139–43.
Walling HW. Primary hyperhidrosis increases the risk of cutaneous infection: a case – control study of 387 patients. J Am Acad Dermatol. 2009;61(2):242–6.
Lee HJ, Ha SJ, Ahn WK, Kim D, Park YM, Byun DG, et al. Clinical evaluation of atopic hand-foot dermatitis. Pediatr Dermatol. 2001;18(2):102–6.
Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51(2):241–8.
Adar R, Kurchin A, Zweig A, Mozes M. Palmar hyperhidrosis and its surgical treatment: a report of 100 cases. Ann Surg. 1977;186(1):34–41.
Hashmonai M, Kopelman D, Assalia A. The treatment of primary palmar hyperhidrosis: a review. Surg Today. 2000;30(3):211–8.
Lear W, Kessler E, Solish N, Glaser DA. An epidemiological study of hyperhidrosis. Dermatol Surg. 2007;33(1 Spec No):S69–75.
Higashimoto I, Yoshiura K, Hirakawa N, Higashimoto K, Soejima H, Totoki T, et al. Primary palmar hyperhidrosis locus maps to 14q11.2-q13. Am J Med Genet A. 2006;140(6):567–72.
Kaufmann H, Saadia D, Polin C, Hague S, Singleton A, Singleton A. Primary hyperhidrosis – evidence for autosomal dominant inheritance. Clin Auton Res. 2003;13(2):96–8.
Hoorens I, Ongenae K. Primary focal hyperhidrosis: current treatment options and a step-by-step approach. J Eur Acad Dermatol Venereol. 2012;26(1):1–8.
Kippenberger S, Havlicek J, Bernd A, Thaci D, Kaufmann R, Meissner M. “Nosing Around” the human skin: what information is concealed in skin odour? Exp Dermatol. 2012;21(9):655–9.
Karaca S, Kulac M, Uz E, Barutcu I, Yilmaz HR. Is nitric oxide involved in the pathophysiology of essential hyperhidrosis? Int J Dermatol. 2007;46(10):1027–30.
Shimizu Y, Sakai M, Umemura Y, Ueda H. Expression of endothelial nitric oxide synthase in human eccrine clear cells. Br J Dermatol. 1997;136(4):572–4.
Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol. 1989;20(4):537–63.
Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51(2):274–86.
Hamm H, Naumann MK, Kowalski JW, Kutt S, Kozma C, Teale C. Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology. 2006;212(4):343–53.
Bahmer FA, Sachse MM. Hyperhidrosis area and severity index. Dermatol Surg. 2008;34(12):1744–5.
Ambrogi V, Campione E, Mineo D, Paterno EJ, Pompeo E, Mineo TC. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis. Ann Thorac Surg. 2009;88(1):238–45.
Aydemir EH, Kalkan MT, Karakoc Y. Quantitative effect of anodal current in the treatment of primary hyperhidrosis by direct electrical current. Int J Dermatol. 2006;45(7):862–4.
Amir M, Arish A, Weinstein Y, Pfeffer M, Levy Y. Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): preliminary results. Isr J Psychiatry Relat Sci. 2000;37(1):25–31.
Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol. 1997;136(3):305–14.
OCEBM. The Oxford 2011 level of evidence. www.cebm.net/index.aspx?o=5653. 2012. 9-6-2012. Ref Type: Online Source
Holzle E, Braun-Falco O. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution. Br J Dermatol. 1984;110(4):399–403.
Benohanian A, Dansereau A, Bolduc C, Bloom E. Localized hyperhidrosis treated with aluminum chloride in a salicylic acid gel base. Int J Dermatol. 1998;37(9):701–3.
Flanagan KH, Glaser DA. An open-label trial of the efficacy of 15 % aluminum chloride in 2 % salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis. J Drugs Dermatol. 2009;8(5):477–80.
Innocenzi D, Ruggero A, Francesconi L, Lacarrubba F, Nardone B, Micali G. An open-label tolerability and efficacy study of an aluminum sesquichlorohydrate topical foam in axillary and palmar primary hyperhidrosis. Dermatol Ther. 2008;21 Suppl 1:S27–30.
Goh CL. Aluminum chloride hexahydrate versus palmar hyperhidrosis. Evaporimeter assessment. Int J Dermatol. 1990;29(5):368–70.
Bergstresser PR, Quero R. Treatment of hyperhidrosis with topical methenamine. Int J Dermatol. 1976;15(6):452–5.
Pagliarello C, Paradisi M, Paradisi A. Reply to: “Primary focal hyperhidrosis: current treatment options and a step-by-step approach.”. J Eur Acad Dermatol Venereol. 2012;26(9):1172.
Cullen SI. Topical methenamine therapy for hyperhidrosis. Arch Dermatol. 1975;111(9):1158–60.
Seukeran DC, Highet AS. The use of topical glycopyrrolate in the treatment of hyperhidrosis. Clin Exp Dermatol. 1998;23(5):204–5.
Kavanagh GM, Burns C, Aldridge RD. Topical glycopyrrolate should not be overlooked in treatment of focal hyperhidrosis. Br J Dermatol. 2006;155(2):487.
Levit F. Simple device for treatment of hyperhidrosis by iontophoresis. Arch Dermatol. 1968;98(5):505–7.
Chia HY, Tan AS, Chong WS, Tey HL. Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis. J Eur Acad Dermatol Venereol. 2012;26(9):1167–70.
Davarian S, Kalantari KK, Rezasoltani A, Rahimi A. Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis. Australas J Dermatol. 2008;49(2):75–9.
Kavanagh GM, Shams K. Botulinum toxin type A by iontophoresis for primary palmar hyperhidrosis. J Am Acad Dermatol. 2006;55(5 Suppl):S115–7.
Kavanagh GM, Oh C, Shams K. BOTOX delivery by iontophoresis. Br J Dermatol. 2004;151(5):1093–5.
Na GY, Park BC, Lee WJ, Park DJ, Kim DW, Kim MN. Control of palmar hyperhidrosis with a new “dry-type” iontophoretic device. Dermatol Surg. 2007;33(1):57–61.
Sato K, Timm DE, Sato F, Templeton EA, Meletiou DS, Toyomoto T, et al. Generation and transit pathway of H+ is critical for inhibition of palmar sweating by iontophoresis in water. J Appl Physiol. 1993;75(5):2258–64.
Hill AC, Baker GF, Jansen GT. Mechanism of action of iontophoresis in the treatment of palmar hyperhidrosis. Cutis. 1981;28(1):69–70. 72.
Hill BH. Poldine iontophoresis in the treatment of palmar and plantar hyperhidrosis. Australas J Dermatol. 1976;17(3):92–3.
Abell E, Morgan K. The treatment of idiopathic hyperhidrosis by glycopyrronium bromide and tap water iontophoresis. Br J Dermatol. 1974;91(1):87–91.
Dolianitis C, Scarff CE, Kelly J, Sinclair R. Iontophoresis with glycopyrrolate for the treatment of palmoplantar hyperhidrosis. Australas J Dermatol. 2004;45(4):208–12.
Swartling C, Naver H, Pihl-Lundin I, Hagforsen E, Vahlquist A. Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin. J Am Acad Dermatol. 2004;51(5):739–45.
Shams K, Kavanagh GM. Immediate reduction in sweat secretion with electric current application in primary palmar hyperhidrosis. Arch Dermatol. 2011;147(2):241–2.
Maillard H, Fenot M, Bara C, Celerier P. Therapeutic value of moderate-dose oxybutynin in extensive hyperhidrosis. Ann Dermatol Venereol. 2011;138(10):652–6.
Krogstad AL, Skymne A, Pegenius G, Elam M, Wallin BG. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis. Br J Dermatol. 2005;152(2):329–33.
Hund M, Sinkgraven R, Rzany B. Randomized, placebo-controlled, double blind clinical trial for the evaluation of the efficacy and safety of oral methantheliniumbromide (Vagantin) in the treatment of focal hyperhidrosis. J Dtsch Dermatol Ges. 2004;2(5):343–9.
Muller C, Berensmeier A, Hamm H, Dirschka T, Reich K, Fischer T, et al. Efficacy and safety of methantheline bromide (Vagantin(®)) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol. 2013;27(10):1278–84.
Paller AS, Shah PR, Silverio AM, Wagner A, Chamlin SL, Mancini AJ. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis. J Am Acad Dermatol. 2012;67(5):918–23.
Bajaj V, Langtry JA. Use of oral glycopyrronium bromide in hyperhidrosis. Br J Dermatol. 2007;157(1):118–21.
Wolosker N, De Campos JR, Kauffman P, Puech-Leao P. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg. 2012;55(6):1696–700.
Walling HW. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine. J Am Acad Dermatol. 2012;66(3):387–92.
Wozniacki L, Zubilewicz T. Primary hyperhidrosis controlled with oxybutynin after unsuccessful surgical treatment. Clin Exp Dermatol. 2009;34(8):e990–1.
Schollhammer M, Misery L. Treatment of hyperhidrosis with oxybutynin. Arch Dermatol. 2007;143(4):544–5.
Wollina U, Karamfilov T. Botulinum toxin A for palmar hyperhidrosis. J Eur Acad Dermatol Venereol. 2001;15(6):555–8.
Solomon BA, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol. 2000;42(6):1026–9.
Doft MA, Hardy KL, Ascherman JA. Treatment of hyperhidrosis with botulinum toxin. Aesthet Surg J. 2012;32(2):238–44.
de Almeida AR, Kadunc BV, de Oliveira EM. Improving botulinum toxin therapy for palmar hyperhidrosis: wrist block and technical considerations. Dermatol Surg. 2001;27(1):34–6.
Cerfolio RJ, De Campos JR, Bryant AS, Connery CP, Miller DL, DeCamp MM, et al. The society of thoracic surgeons expert consensus for the surgical treatment of hyperhidrosis. Ann Thorac Surg. 2011;91(5):1642–8.
Reisfeld R, Nguyen R, Pnini A. Endoscopic thoracic sympathectomy for treatment of essential hyperhidrosis syndrome: experience with 650 patients. Surg Laparosc Endosc Percutan Tech. 2000;10(1):5–10.
Inan K, Goksel OS, Ucak A, Temizkan V, Karaca K, Ugur M, et al. Thoracic endoscopic surgery for hyperhidrosis: comparison of different techniques. Thorac Cardiovasc Surg. 2008;56(4):210–3.
Vorkamp T, Foo FJ, Khan S, Schmitto JD, Wilson P. Hyperhidrosis: evolving concepts and a comprehensive review. Surgeon. 2010;8(5):287–92.
Gossot D, Kabiri H, Caliandro R, Debrosse D, Girard P, Grunenwald D. Early complications of thoracic endoscopic sympathectomy: a prospective study of 940 procedures. Ann Thorac Surg. 2001;71(4):1116–9.
Zacherl J, Huber ER, Imhof M, Plas EG, Herbst F, Fugger R. Long-term results of 630 thoracoscopic sympathicotomies for primary hyperhidrosis: the Vienna experience. Eur J Surg Suppl. 1998;580:43–6.
Lin TS. Transthoracic endoscopic sympathectomy for palmar and axillary hyperhidrosis in children and adolescents. Pediatr Surg Int. 1999;15(7):475–8.
Hofbauer GF, Nestle FO. Irritant contact dermatitis of the hands following thoracic sympathectomy. Contact Dermatitis. 2000;42(2):119–20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hougaard, M.G., Thyssen, J.P. (2014). Treatment of Hand Eczema Caused by Hyperhidrosis. In: Alikhan, A., Lachapelle, JM., Maibach, H. (eds) Textbook of Hand Eczema. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39546-8_34
Download citation
DOI: https://doi.org/10.1007/978-3-642-39546-8_34
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39545-1
Online ISBN: 978-3-642-39546-8
eBook Packages: MedicineMedicine (R0)